NCT06608511 2025-12-17
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
University of Wisconsin, Madison
Recruiting
Clinical Trials
12 trialsNCT07148245 2025-11-10
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
University of California, San Francisco
Recruiting
NCT06605404 2025-08-14
Pan-tumor MRD Study
Paradigm Health
Recruiting
NCT05819827 2025-04-27
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
Terminated
NCT05940311 2024-11-27
VerSiLiB
Regina Elena Cancer Institute
Recruiting
NCT03267381 2023-12-14
Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy
Vanderbilt-Ingram Cancer Center
Completed
NCT05817149 2023-04-18
Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study
Aalborg University Hospital
Completed
NCT00507325 2022-09-02
Sample Collection From Melanoma Patients
M.D. Anderson Cancer Center
Terminated
NCT04136470 2020-08-10
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
Ardigen
Unknown
NCT04493723 2020-07-30
Serial Tumour Biopsies and Blood Biomarkers in Melanoma
The Christie NHS Foundation Trust
Recruiting
NCT01528774 2017-07-26
CTC
Comprehensive Cancer Centers of Nevada
Completed
NCT00615095 2011-04-20
Differential Risks for Melanoma: p16 and DNA Repair
Memorial Sloan Kettering Cancer Center
Completed